Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Gastric carcinoma with osteoclast-like giant cells coexisting with gastrointestinal spindle cell tumor..
Case Rep Pathol. 2013, 240758.
(2013). Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients..
Basic Clin Pharmacol Toxicol. 102(6), 559-62.
(2008). Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents..
J Crohns Colitis.
(2021). Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease..
Neurosci Lett. 323(1), 81-3.
(2002).
(2006).
No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease..
Neurosci Lett. 322(3), 192-4.
(2002). Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications..
Diabetes Obes Metab. 24(9), 1702-1720.
(2022). Nonalcoholic fatty liver disease: lifestyle and quality of life..
Hormones (Athens).
(2021). Olanzapine: evaluation of the in vivo cytogenetic effect..
Hum Psychopharmacol. 30(3), 189-92.
(2015).
(2024).
Potential use of pericardial cTnI, Mg and Ca in the forensic investigation of seawater drowning in Greece: An initial assessment..
Leg Med (Tokyo). 23, 30-33.
(2016). Psychotic episode associated with sertraline and drug-related delirium: a case report..
J Clin Psychopharmacol. 34(4), 527-9.
(2014). Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis..
J Pers Med. 13(7),
(2023). The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis..
Psychiatry Res. 291, 113246.
(2020). The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease.
Expert Review of Clinical Pharmacology. 1 - 10.
(2023). The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease..
Expert Rev Clin Pharmacol. 1-10.
(2023).
(2014). Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020). Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease..
Eur J Pharmacol. 907, 174272.
(2021). Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus..
Acta Ophthalmol. 87(5), 555-8.
(2009). Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives..
Eur J Med Chem. 46(9), 3845-50.
(2011). Tirzepatide for Diabetes and Obesity: A New Window to the Treatment of Non-alcoholic Steatohepatitis.
Current Medicinal Chemistry. 30,
(2023).
(2023).
(2020).